{"id":2058,"date":"2026-07-29T23:18:07","date_gmt":"2026-07-29T14:18:07","guid":{"rendered":"https:\/\/urology.dept.med.gunma-u.ac.jp\/?p=2058"},"modified":"2026-07-30T08:21:54","modified_gmt":"2026-07-29T23:21:54","slug":"2024%e5%b9%b4%e3%80%80%e6%a5%ad%e7%b8%be%e3%83%bb%e8%ab%96%e6%96%87","status":"publish","type":"post","link":"https:\/\/urology.dept.med.gunma-u.ac.jp\/?p=2058","title":{"rendered":"2024\u5e74"},"content":{"rendered":"
    \n
  1. \n

    Arai S, Gao Y, Yu Z, Xie L, Wang L, Zhang T, Nouri M, Chen S, Asara JM, Balk SP. A carboxy-terminal ubiquitylation site regulates androgen receptor activity. 2024\u5e741\u6708 Commun Biol 7(1):25 10.1038\/s42003-023-05709-x.\n<\/li>\n

  2. \n

    Arai S. Editorial Comment on Epigenetic alterations in urothelial bladder cancer associated with disease outcomes. 2024\u5e743\u6708 Int J Urol 31(3):229-230 10.1111\/iju.15361\n<\/li>\n

  3. \n

    Sawada T, Igarashi A, Arai S, Ohtsu A, Fujizuka Y, Nakazawa S, Sekine Y, Koike H, Furuya Y, Suzuki K. Afebrile tuberculous prostatic abscess with rectal fistula after intravesical Bacillus Calmette-Gu\u00e9rin immunotherapy. 2024\u5e7411\u6708 IJU Case Report 8(1):69-72 10.1002iju5.12814\n<\/li>\n

  4. \n

    \u95a2\u6839\u82b3\u5cb3\u3001\u9234\u6728\u548c\u6d69\u3001\u733f\u6728\u548c\u4e45 \u707d\u5bb3\u6642\u30fb\u5e73\u6642\u306e\u900f\u6790\u6db2\u7528\u306e\u6c34\u78ba\u4fdd 2024\u5e7411\u6708 \u900f\u6790\u30d5\u30ed\u30f3\u30c6\u30a3\u30a2 34(4):8-10\n<\/li>\n

  5. \n

    Miyazawa Y, Koike H, Oka D, Kawamura H, Kubo N, Miyasaka Y, Onishi M, Syuto T, Sekine Y, Matsui H, Ohno T, Suzuki K. Comparison of sexual function after robot-assisted radical prostatectomy and carbon-ion radiotherapy for Japanese prostate cancer patients using propensity score matching. 2024\u5e745\u6708 BMC cancer 24(1):300 10.1186\/\uff5312885-024-12062-7\n<\/li>\n

  6. \n

    Miyazawa Y, Nakayama H, Kawamura H, Miyasaka Y, Onishi M, Kaminura T, Sekine Y, Matsui H, Ohno T, Suzuki K. Analysis of uriary function and prostate volume changes in localized prostate cancer patients treated with carbon-ion radiotherapy; a prospedctive study. 2024\u5e7411\u6708 Radiat Oncol 19(1):165 10.1186\/s13014-024-0563-x\n<\/li>\n

  7. \n

    \u4f0a\u85e4\u4e00\u4eba\u3001\u95a2\u6839\u82b3\u5cb3\u3001\u5927\u6728\u3000\u4eae\u3001\u85e4\u585a\u96c4\u53f8\u3001\u677e\u672c\u548c\u4e45\u3001\u53e4\u4f5c\u3000\u671b\u3001\u7af9\u6fa4\u3000\u8c4a\u3001\u9234\u6728\u548c\u6d69\u3001\u6751\u4e95\u3000\u52dd\u3001\u5e73\u5c3e\u4f73\u5f66\u3001\u5c71\u4e2d\u82f1\u58fd \u524d\u7acb\u817a\u304c\u3093\u691c\u8a3a\u7814\u7a76\u9032\u6357\u72b6\u6cc1\u5831\u544a\uff1a\u5f8c\u308d\u5411\u304d\u7814\u7a76\u306e\u6982\u8981\u30682022\u5e74\u5ea6\u4f0a\u52e2\u5d0e\u30b3\u30db\u30fc\u30c8\u306e\u691c\u8a3a\u7d50\u679c 2024\u5e748\u6708 \u6ccc\u5c3f\u5668\u5916\u79d1 37(8):972-976\n<\/li>\n

  8. \n

    \u4f0a\u85e4\u4e00\u4eba\u3001\u52a0\u702c\u5609\u660e\u3001\u5e73\u5c3e\u4f73\u5f66\u3001\u5927\u6728\u3000\u4eae\u3001\u85e4\u585a\u96c4\u53f8\u3001\u5c71\u672c\u3000\u5de7\u3001\u8d64\u5009\u529f\u4e00\u90ce\u3001\u6751\u4e95\u3000\u52dd\u3001\u5c71\u4e2d\u82f1\u58fd \u4eba\u9593\u30c9\u30c3\u30af\u65bd\u8a2d\u306b\u304a\u3051\u308b\u524d\u7acb\u817a\u304c\u3093\u691c\u8a3a\u30a2\u30f3\u30b1\u30fc\u30c8\u96c6\u8a08\u5831\u544a(\u7b2c18\u56de\u8abf\u67fb)\u20152022\u5e74\u5ea6\u2015 2024\u5e748\u6708 \u6ccc\u5c3f\u5668\u5916\u79d1 37(8):977-981\n<\/li>\n

  9. \n

    Oka D, Sekine Y, Tsuji Y, Nakayama H, Miyazawa Y, Arai S, Koike H, Suzuki K. Simvastatin Enhances the Radiosensitivity of Androgen-independent Prostate Cancer Cells via Inhibition of RAD51 Expression. 2024\u5e741\u6708 Anticancer Res 44(1):93-98 10.21873\/anticanres.16791\n<\/li>\n

  10. \n

    Kamiyama A, Takazawa T, Matsui Y, Nagumo K, Arai S, Saito S. Investigation of the optimal method of oxygen administration with simultaneous use of a surgical mask in postoperative patients:a randomized cross-over study. 2024\u5e749\u6708 JA Clinical Reports 10(1):60 10.1186\/\uff5340981-024-00741-0\n<\/li>\n

  11. \n

    \u66f2\u3000\u53cb\u5f18\u3001\u6df1\u5800\u80fd\u7acb\u3001\u5c0f\u5009\u6cbb\u4e4b\u3001\u9234\u6728\u548c\u6d69\u3001\u9ed2\u6fa4\u3000\u529f \u810a\u9ac4\u75c5\u5909\u306e\u4e2d\u306b\u3069\u3093\u306a\u795e\u7d4c\u75be\u60a3\u304c\u96a0\u308c\u3066\u3044\u308b\u306e\u304b\uff1f\uff5e\u795e\u7d4c\u5185\u79d1\u53d7\u8a3a\u524d\u306b\u6ccc\u5c3f\u5668\u79d1\u53d7\u8a3a\u6b74\u306e\u3042\u308b\u795e\u7d4c\u75be\u60a3\u306b\u95a2\u3059\u308b\u691c\u8a0e\u304b\u3089\uff5e 2024\u5e747\u6708 \u65e5\u672c\u6392\u5c3f\u6a5f\u80fd\u5b66\u4f1a\u8a8c 34(2):373-382\n<\/li>\n

  12. \n

    Ishizaki M, Hasumi M, Muramatsu K, Shimizu N. Prostate neuroendocrine carcinoma successfully treated with etoposide and cisplatin. 2024\u5e749\u6708 IJU Case Reports 7(6):491-494 10.1002\/iju5.12787\n<\/li>\n

  13. \n

    \u4f0a\u85e4\u4e00\u4eba phi\u3092\u6d3b\u7528\u3057\u305f\u524d\u7acb\u817a\u304c\u3093\u8a3a\u65ad\u30d5\u30ed\u30fc 2024\u5e743\u6708 \u65e5\u672c\u304c\u3093\u691c\u8a3a\u30fb\u8a3a\u65ad\u5b66\u4f1a\u8a8c\u3000 31(3) :5-10\n<\/li>\n

  14. \n

    \u4f0a\u85e4\u4e00\u4eba “\u816b\u760d\u30de\u30fc\u30ab\u30fc\u3000\uff0d\u4f7f\u3044\u65b9\u306e\u30b3\u30c4\u3068\u30d4\u30c3\u30c8\u30d5\u30a9\u30fc\u30eb\uff0d
    \n\u524d\u7acb\u817a\u304c\u3093\u2460\u30b9\u30af\u30ea\u30fc\u30cb\u30f3\u30b0\u30fb\u8a3a\u65ad\uff08PSA\uff09” 2024\u5e744\u6708 \u65e5\u672c\u533b\u5e2b\u4f1a\u96d1\u8a8c 153(1):74-75\n<\/li>\n

  15. \n

    \u4f0a\u85e4\u4e00\u4eba\u3001\u5927\u6728\u3000\u4eae\u3001\u53e4\u8c37\u6d0b\u4ecb\u3001\u99ac\u5834\u606d\u5b50\u3001\u66f2\u3000\u53cb\u5f18\u3001\u5c0f\u5009\u6cbb\u4e4b\u3001\u9ed2\u6fa4\u3000\u529f \u5f53\u9662\u306b\u304a\u3051\u308b\u30aa\u30ea\u30b4\u30e1\u30bf\u524d\u7acb\u817a\u764c\u306b\u5bfe\u3059\u308b\u7a4d\u6975\u7684\u5c40\u6240\u6cbb\u7642\u4ecb\u5165\u65b9\u91dd\u3068Metastasis-Directed Therapy\u9069\u5fdc\u306e\u63a2\u7d22 2024\u5e741\u6708 \u7fa4\u99ac\u533b\u5b66 118:71-74\n<\/li>\n

  16. \n

    \u798f\u7530\u4e00\u5c06\u3001\u6a4b\u672c\u98db\u9ce5\u3001\u4e2d\u5c71\u7d18\u53f2\u3001\u7267\u91ce\u6b66\u6717\u3001\u60a6\u6c38\u3000\u5fb9\u3001\u658e\u85e4\u4f73\u9686\u3001\u7af9\u6fa4\u3000\u8c4a\u3001\u5c0f\u6797\u5e79\u7537 \u96c6\u5b66\u7684\u6cbb\u7642\u3067\u6551\u547d\u3057\u5f97\u305f\u7d50\u77f3\u6027\u814e\u76c2\u814e\u708e\u306b\u4f34\u3046\u6557\u8840\u75c7\u6027\u30b7\u30e7\u30c3\u30af\u306e\uff11\u4f8b 2024\u5e743\u6708 \u6ccc\u5c3f\u5668\u5916\u79d1 37(3):238-241\n<\/li>\n

  17. \n

    \u53e4\u8c37\u6d0b\u4ecb\u3001\u5927\u6728\u3000\u4eae\u3001\u4f0a\u85e4\u4e00\u4eba\u3001\u99ac\u5834\u606d\u5b50\u3001\u66f2\u3000\u53cb\u5f18\u3001\u5c0f\u5009\u6cbb\u4e4b\u3001\u9ed2\u6fa4\u3000\u529f \u5f53\u9662\u306b\u304a\u3051\u308b\u30ed\u30dc\u30c3\u30c8\u652f\u63f4\u624b\u8853\u306e\u5c0e\u5165\u7d4c\u9a13 2024\u5e741\u6708 \u7fa4\u99ac\u533b\u5b66 118:17-20\n<\/li>\n

  18. \n

    \u66f2\u3000\u53cb\u5f18\u3001\u99ac\u5834\u606d\u5b50\u3001\u53e4\u8c37\u6d0b\u4ecb\u3001\u5927\u6728\u3000\u4eae\u3001\u5c0f\u5009\u6cbb\u4e4b\u3001\u4f0a\u85e4\u4e00\u4eba\u3001\u9ed2\u6fa4\u3000\u529f \u9ed2\u6ca2\u75c5\u9662\u306b\u304a\u3051\u308b\u30dc\u30c4\u30ea\u30cc\u30b9\u6bd2\u7d20\u8180\u80f1\u58c1\u5185\u6ce8\u5165\u7642\u6cd5\u306e\u5c0e\u5165 2024\u5e741\u6708 \u7fa4\u99ac\u533b\u5b66 118:75-80\n<\/li>\n

  19. \n

    \u5bae\u4e45\u4fdd\u771f\u610f\u3001\u4f0a\u85e4\u4e00\u4eba \u524d\u7acb\u817a\u816b\u760d\u30de\u30fc\u30ab\u30fc\uff08PSA:\u524d\u7acb\u817a\u7279\u7570\u6297\u539f\uff0cphi:\u30d7\u30ed\u30b9\u30c6\u30fc\u30c8\u30d8\u30eb\u30b9\u30a4\u30f3\u30c7\u30c3\u30af\u30b9\uff09 2024\u5e7412\u6708 \u81e8\u5e8a\u691c\u67fb\u30ac\u30a4\u30c92025\u5e74\u6539\u8a02\u7248\n<\/li>\n

  20. \n

    \u5929\u5ddd\u53cb\u4ecb\u3001\u6b66\u4e95\u6643\u53f8\u3001\u898b\u7530\u3000\u5c0a\u3001\u5c71\u5d0e\u7267\u5b50\u3001\u4e95\u6238\u8c37\u6075\u3001\u77e2\u5cf6\u7fa9\u662d\u3001\u4e09\u8f2a\u7be4\u53f2\u3001\u9ed2\u6fa4\u3000\u529f \u4eba\u9593\u30c9\u30c3\u30af\u306e\u80c3X\u7dda\u691c\u67fb\u306b\u304a\u3051\u308b\u30d1\u30cb\u30c3\u30af\u753b\u50cf\u5bfe\u5fdc\u3000\u2015\u6162\u6027\u80c3\u708e\u3067\u306e\u5bfe\u5fdc\u2015 2024\u5e741\u6708 \u7fa4\u99ac\u533b\u5b66 118:135-139\n<\/li>\n

  21. \n

    \u98ef\u585a \u667a\u6a39\u3001\u4e2d\u5d8b\u4f38\u4e45\u3001\u9ed2\u6fa4\u3000\u529f \u75c5\u68df\u81ea\u7acb\u5224\u5b9a\u30d7\u30ed\u30bb\u30b9\u306e\u4f5c\u6210\u3068\u691c\u8a3c 2024\u5e741\u6708 \u7fa4\u99ac\u533b\u5b66 118:109-114\n<\/li>\n

  22. \n

    \u5927\u7af9\u4e3b\u4fe1\u3001\u67f4\u5d0e\u5f18\u5d07\u3001\u5929\u5ddd\u53cb\u4ecb\u3001\u9577\u3000\u7460\u7f8e\u3001\u9577\u8c37\u5ddd\u5f69\u9999\u3001\u6d66\u91ce\u6668\u592a\u90ce\u3001\u4e39\u6cbb\u3000\u7ffc\u3001\u5c0f\u6e15\u9054\u4e5f\u3001\u898b\u7530\u3000\u5c0a\u3001\u6b66\u4e95\u6643\u53f8\u3001\u9ed2\u6fa4\u3000\u529f \u5f53\u9662\u306e\u653e\u5c04\u7dda\u79d1\u6280\u5e2b\u306b\u3088\u308b\u753b\u50cf\u8aad\u5f71\u30ec\u30dd\u30fc\u30c8\u306e\u898b\u843d\u3068\u3057\u9632\u6b62\u5bfe\u7b56 2024\u5e741\u6708 \u7fa4\u99ac\u533b\u5b66 118:127-129\n<\/li>\n

  23. \n

    \u6728\u5185\u7d75\u91cc\u9999\u3001\u6a2a\u5c71\u3000\u52c7\u3001\u4e09\u8f2a\u7be4\u53f2\u3001\u4f0a\u85e4\u4e00\u4eba\u3001\u9ed2\u6fa4\u3000\u529f \u5916\u6765\u30fb\u4eba\u9593\u30c9\u30c3\u30af\u5229\u7528\u8005\u306e\u904b\u52d5\u7642\u6cd5\u30fb\u98df\u4e8b\u6307\u5c0e\u5b9f\u65bd\u306b\u304a\u3051\u308b\u4f53\u7d44\u6210\u5909\u5316 2024\u5e741\u6708 \u7fa4\u99ac\u533b\u5b66 118:151-154\n<\/li>\n

  24. \n

    \u5c0f\u6797\u5145\u5178\u3001\u77f3\u95a2\u7d14\u9999\u3001\u9ad8\u91ce\u96c5\u5b50\u3001\u4e95\u6238\u8c37\u6075\u3001\u4e09\u8f2a\u7be4\u53f2\u3001\u9ed2\u6fa4\u3000\u529f \u8077\u54e1\u5065\u8a3a\u306b\u304a\u3051\u308b\u7761\u7720\u4f11\u990a\u611f\u306e\u8abf\u67fb 2024\u5e741\u6708 \u7fa4\u99ac\u533b\u5b66 118:91-96\n<\/li>\n

  25. \n

    \u5c0f\u6e15\u9054\u4e5f\u3001\u67f4\u5d0e\u5f18\u5d07\u3001\u5929\u5ddd\u53cb\u4ecb\u3001\u9577\u3000\u7460\u7f8e\u3001\u6d66\u91ce\u6668\u592a\u90ce\u3001\u9577\u8c37\u5ddd\u5f69\u9999\u3001\u4e39\u6cbb\u3000\u7ffc\u3001\u5927\u7af9\u4e3b\u4fe1\u3001\u898b\u7530\u3000\u5c0a\u3001\u9ed2\u6fa4\u3000\u529f \u653e\u5c04\u7dda\u90e8\u306b\u304a\u3051\u308b\u65b0\u578b\u30b3\u30ed\u30ca\u30a6\u30a4\u30eb\u30b9\u611f\u67d3\u5bfe\u7b56\u306b\u3064\u3044\u3066 2024\u5e741\u6708 \u7fa4\u99ac\u533b\u5b66 118:115-117\n<\/li>\n

  26. \n

    \u9152\u4e95\u82f1\u660e\u3001\u5cb8\u3000\u6771\u5f66\u3001\u6d45\u91ce\u76ee\u548c\u5e83\u3001\u4e09\u8f2a\u7be4\u53f2\u3001\u77e2\u5cf6\u7fa9\u662d\u3001\u9ed2\u6fa4\u3000\u529f \u4eba\u9593\u30c9\u30c3\u30af\u306b\u304a\u3051\u308b\u5a66\u4eba\u79d1\u5065\u8a3a\u3067\u306e\u7d4c\u815f\u30a8\u30b3\u30fc\u691c\u67fb\u306e\u5fc5\u8981\u6027\u3068\u305d\u306e\u52b9\u679c 2024\u5e741\u6708 \u7fa4\u99ac\u533b\u5b66 118:85-89\n<\/li>\n

  27. \n

    \u9ad8\u91ce\u96c5\u5b50\u3001\u77f3\u95a2\u7d14\u9999\u3001\u9326\u6238\u3000\u5d07\u3001\u5409\u539f\u5c0a\u6a39\u3001\u4e09\u8f2a\u7be4\u53f2\u3001\u4f0a\u85e4\u4e00\u4eba\u3001\u9ed2\u6fa4\u3000\u529f \u5f53\u533b\u7642\u6cd5\u4eba\u306b\u304a\u3051\u308b\u5065\u5eb7\u7ba1\u7406\u5ba4\u306e\u5f79\u5272\u3068\u8077\u54e1\u306e\u5065\u8a3a\u7d50\u679c\u306e\u63a8\u79fb 2024\u5e741\u6708 \u7fa4\u99ac\u533b\u5b66 118:97-102\n<\/li>\n

  28. \n

    \u6b66\u4e95\u79cb\u99ac\u3001\u539f\u7530\u548c\u5f66\u3001\u9ad8\u91ce\u96c5\u5b50\u3001\u77f3\u95a2\u7d14\u9999\u3001\u4e09\u8f2a\u7be4\u53f2\u3001\u9ed2\u6fa4\u3000\u529f \u65b0\u578b\u30b3\u30ed\u30ca\u30a6\u30a4\u30eb\u30b9\u306b\u5bfe\u3059\u308b\u30ef\u30af\u30c1\u30f3\u63a5\u7a2e\u5f8c\u306e\u6297\u4f53\u4fa1\u306e\u63a8\u79fb 2024\u5e741\u6708 \u7fa4\u99ac\u533b\u5b66 118:141-146\n<\/li>\n

  29. \n

    \u591a\u80e1\u5948\u592e\u5b50\u3001\u4e09\u8f2a\u5343\u4ee3\u679d\u3001\u661f\u91ce\u7531\u91cc\u5b50\u3001\u5c71\u5d0e\u7267\u5b50\u3001\u671b\u6708\u9759\u4f73\u3001\u767d\u4e95\u5fb3\u592b\u3001\u4e09\u8f2a\u7be4\u53f2\u3001\u77e2\u5cf6\u7fa9\u662d\u3001\u9ed2\u6fa4\u3000\u529f \u4eba\u9593\u30c9\u30c3\u30af\u306b\u304a\u3051\u308b\u30bf\u30d6\u30ec\u30c3\u30c8\u8a98\u5c0e\u6848\u5185\u30b7\u30b9\u30c6\u30e0\u5c0e\u5165\u306e\u52b9\u679c 2024\u5e741\u6708 \u7fa4\u99ac\u533b\u5b66 118:119-125\n<\/li>\n

  30. \n

    Horiguchi A, Shinchi M, Hirano Y, Asanuma H Ishiura Y, Inoue K, Kanematsu A, Tabei T, Tamura Y, Nakajima Y, Moriya K, Yagihashi Y, Fukagai T, Fujii Y. Clinical questions in the Japanese Urological Association\u2019s 2024 clinical practice guidelines for urethral strictures. 2024\u5e749\u6708 Int J Urol 31(9): 956\uff5e967 10.1111\/iju.15512\n<\/li>\n

  31. \n

    \u5800\u53e3\u660e\u7537\u3001\u6df1\u8c9d\u9686\u5fd7\u3001\u85e4\u4e95\u9756\u4e45\u3001\u6d45\u6cbc\u3000\u5b8f\u3001\u77f3\u6d66\u5609\u4e4b\u3001\u4e95\u4e0a\u5e78\u6cbb\u3001\u517c\u677e\u660e\u5f18\u3001\u7530\u90e8\u4e95\u6b63\u3001\u7530\u6751\u82b3\u7f8e\u3001\u4e2d\u5cf6\u6d0b\u4ecb\u3001\u5b88\u5c4b\u4ec1\u5f66\u3001\u516b\u6728\u6a4b\u7950\u4eae\u3001\u65b0\u5730\u7950\u4ecb\u3001\u5e73\u91ce\u88d5\u8cc7 \u5c3f\u9053\u72ed\u7a84\u75c7\u8a3a\u7642\u30ac\u30a4\u30c9\u30e9\u30a4\u30f3\u30002024\u5e74\u7248 2024\u5e744\u6708 \u65e5\u672c\u6ccc\u5c3f\u5668\u79d1\u5b66\u4f1a\u7de8,\u533b\u5b66\u56f3\u66f8\u51fa\u7248\n<\/li>\n

  32. \n

    Matsubara N, Miura Y, Nishiyama H, Taoka R, Kojima T, Shimizu N, Hwang J, Ote T, Oyama R, Toyoizumi K, Mukhopadhyay S, Triantos S, Deprince K, Loriot Y. Phase 3 THOR Japanese subgroup analysis: erdafitinib in advanced or metastatic urothelial cancer and fibroblast growth factor receptor alterations. 2024\u5e7410\u6708 Int J Clin Oncol 29(10):1516-1527 10.1007\/s10147-024-02583-3\n<\/li>\n

  33. \n

    \u671b\u6708\u9759\u4f73\u3001\u6afb\u4e95\u52dd\u679d\u3001\u7893\u4e95\u6f84\u6c5f\u3001\u4e95\u6238\u8c37\u6075\u3001\u77e2\u5cf6\u7fa9\u662d\u3001\u9ed2\u6fa4\u3000\u529f \u4eba\u9593\u30c9\u30c3\u30af\u306b\u304a\u3051\u308b\u9ad8\u8840\u5727(D\u5224\u5b9a)\u4f8b\u306e\u8840\u5727\u518d\u6e2c\u5b9a\u306e\u610f\u7fa9 2024\u5e741\u6708 \u7fa4\u99ac\u533b\u5b66 118:147-150\n<\/li>\n

  34. \n

    \u4fdd\u7530\u548c\u594f\u3001\u6df1\u6d25\u3000\u7ae0\u3001\u5bae\u4e45\u4fdd\u771f\u610f\u3001\u5c0f\u91ce\u82b3\u5553 2\u578b\u7cd6\u5c3f\u75c5\u60a3\u8005\u306e\u7537\u6027\u5916\u9670\u90e8\u30ab\u30f3\u30b8\u30c0\u75c7 2024\u5e741\u6708 \u7fa4\u99ac\u533b\u5b66 118:27-28\n<\/li>\n

  35. \n

    \u6a2a\u5c71\u3000\u52c7\u3001\u5927\u91ce\u967d\u83ef\u3001\u4e09\u8f2a\u7be4\u53f2\u3001\u4f0a\u85e4\u4e00\u4eba\u3001\u9ed2\u6fa4\u3000\u529f \u30b9\u30c8\u30ec\u30c3\u30c1\u30d7\u30ed\u30b0\u30e9\u30e0\u306e\u30a6\u30a9\u30fc\u30ad\u30f3\u30b0\u901f\u5ea6\u30fb\u30d0\u30e9\u30f3\u30b9\u3078\u306e\u5f71\u97ff\u3000\u904b\u52d5\u7fd2\u6163\u3092\u6709\u3059\u308b\u30d5\u30a3\u30c3\u30c8\u30cd\u30b9\u4f1a\u54e1\u3067\u306e\u4e88\u5099\u7684\u691c\u8a3c 2024\u5e741\u6708 \u7fa4\u99ac\u533b\u5b66 118:131-134\n<\/li>\n

  36. \n

    \u9df2\u5c3e\u548c\u5e78\u3001\u4e2d\u5d8b\u6d69\u8cb4\u3001\u91d1\u4e95\u6075\u7f8e\u3001\u53e4\u8c37\u6d0b\u4ecb\u3001\u99ac\u5834\u606d\u5b50\u3001\u5927\u6728\u3000\u4eae\u3001\u66f2\u3000\u53cb\u5f18\u3001\u5c0f\u5009\u6cbb\u4e4b\u3001\u4f0a\u85e4\u4e00\u4eba\u3001\u4e09\u8f2a\u7be4\u53f2\u3001\u9ed2\u6fa4\u7531\u7f8e\u5b50\u3001\u9ed2\u6fa4\u3000\u529f 5-\u30a2\u30df\u30ce\u30ec\u30d6\u30ea\u30f3\u9178\u3092\u7528\u3044\u305f\u5149\u7dda\u529b\u5b66\u8a3a\u65ad\u4f75\u7528\u7d4c\u5c3f\u9053\u7684\u8180\u80f1\u816b\u760d\u5207\u9664\u8853(fluorescence cystoscopy-assisted TURBT:FL-TURBT)\u306b\u304a\u3051\u308b\u30e1\u30c8\u30af\u30ed\u30d7\u30e9\u30df\u30c9\u306e\u5614\u5410\u6291\u5236\u4f5c\u7528 2024\u5e741\u6708 \u7fa4\u99ac\u533b\u5b66 118:103-107<\/p>\n<\/li>\n<\/ol>\n","protected":false},"excerpt":{"rendered":"

    Arai S, Gao Y, Yu Z, Xie L, Wang L, Zhang T, Nouri M, Chen S, Asara JM, Balk SP. A carboxy-terminal ubiquityla […]<\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[5],"tags":[],"class_list":["post-2058","post","type-post","status-publish","format-standard","hentry","category-achievements"],"_links":{"self":[{"href":"https:\/\/urology.dept.med.gunma-u.ac.jp\/index.php?rest_route=\/wp\/v2\/posts\/2058","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/urology.dept.med.gunma-u.ac.jp\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/urology.dept.med.gunma-u.ac.jp\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/urology.dept.med.gunma-u.ac.jp\/index.php?rest_route=\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/urology.dept.med.gunma-u.ac.jp\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=2058"}],"version-history":[{"count":23,"href":"https:\/\/urology.dept.med.gunma-u.ac.jp\/index.php?rest_route=\/wp\/v2\/posts\/2058\/revisions"}],"predecessor-version":[{"id":2086,"href":"https:\/\/urology.dept.med.gunma-u.ac.jp\/index.php?rest_route=\/wp\/v2\/posts\/2058\/revisions\/2086"}],"wp:attachment":[{"href":"https:\/\/urology.dept.med.gunma-u.ac.jp\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=2058"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/urology.dept.med.gunma-u.ac.jp\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=2058"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/urology.dept.med.gunma-u.ac.jp\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=2058"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}